연구동향 분석
박사

Oncogenic human papillomavirus genotype analysis causing high-grade cervical lesions in Korean and Chinese

이동섭 2015년

논문상세정보
인용/피인용
' Oncogenic human papillomavirus genotype analysis causing high-grade cervical lesions in Korean and Chinese' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • cervical cancer
  • e6/e7 mrna target
  • e6/e7 mrna 목적
  • eastern china
  • hpv genotypes
  • hpv 유전형
  • human papillomavirus
  • molecular diagnosis
  • republic of korea
  • 분자적 진단
  • 인유두종 바이러스
  • 자궁경부암
  • 중국 동부
  • 한국
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,207 0

0.0%

' Oncogenic human papillomavirus genotype analysis causing high-grade cervical lesions in Korean and Chinese' 의 참고문헌

  • zur Hausen H (2009) Papillomaviruses in the causation of humancancers - a brief historical account. Virology 384:260-265.
  • zur Hausen H (2000) Papillomaviruses causing cancer: evasionfrom host-cell control in early events in carcinogenesis. J NatlCancer Inst 92:690-698.
  • de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H(2004) Classification of papillomaviruses. Virology 324:17-27.
  • de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N,Bosch FX (2007) Worldwide prevalence and genotype distributionof cervical human papillomavirus DNA in women with normalcytology: a meta-analysis. Lancet Infect Dis 7:453-459.
  • Yugawa T, Kiyono T (2009). Molecular mechanisms of cervicalcarcinogenesis by high-risk human papillomaviruses: novelfunctions of E6 and E7 oncoproteins. Rev Med Virol 19:97-113.
  • Ylitalo N, S? rensen P, Josefsson AM, Magnusson PK, AndersenPK, Ponten J, Adami HO, Gyllensten UB, Melbye M (2000)Consistent high viral load of human papillomavirus 16 and risk ofcervical carcinoma in situ: a nested case-control study. Lancet355:2194-2198.
  • Xiao-Xiang L, Xing-Li F, Yue-Ping Y, Lei Ji, JY and Ai-Hua S(2014) Human papillomavirus prevalence and type-distributionamong women in Zhejiang province, southeast china: acrosssectionalstudy. BMC Infect Dis 14:708-714.
  • Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM,Parkin DM (1998) International trends in the incidence of cervicalcancer: I. Adenocarcinoma and adenosquamous cell carcinomas. IntJ Cancer 75:536-545.
  • Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M (2013)Triage of Women With Minor Abnormal Cervical Cytology: metaanalysisof the accuracy of an assay targeting messenger ribonucleicacid of 5 high-risk human papillomavirus types. CancerCytopathology 121:675-687.
  • Varnai AD, Bollmann M, Bankfalvi A, Speich N, Schmitt C,Griefingholt H, Kovacs K, Klozoris C, Bollmann R. (2008)Predictive testing of early cervical pre-cancer by detecting humanpapillomavirus E6/E7 mRNA in cervical cytologies up to high-gradesquamous intraepithelial lesions: diagnostic and prognosticimplications. Oncol Rep 19:457-465.
  • Sveinung WS, Silje F, Tore G, Elin SM (2010) Triage of Womenwith Minor Cervical Lesions: Data Suggesting a Test and Treat ? ?96Approach for HPV E6/E7 mRNA Testing. PLoS One 5:e12724-12729.
  • Sun B, He J, Chen X, He M, He Z, Wang Y, Shang Q, Yu L, Wei L(2014) Prevalence and genotype distribution of humanpapillomavirus infection in harbin, Northeast China. Arch Virol159:1027-1032.
  • Stoler MH, Schiffman M (2001) Interobserver reproducibility ofcervical cytologic and histologic interpretations: realistic estimates102from the ASCUS-LSIL Triage Study. JAMA 285: 1500?1505.
  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM(1990) The E6 oncoprotein encoded by human papillomavirus types16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
  • Ruttkay-Nedecky B, Jimenez Jimenez AM, Nejdl L, Chudobova D,Gumulec J, Masarik M, Adam V, Kizek R. (2013) Relevance ofinfection with human papillomavirus: the role of the p53 tumorsuppressor protein and E6/E7 zinc finger proteins (Review). Int JOncol 43:1754-1762.
  • Ronco G, Giorgi-Rossi P, Carozzi F (2008) New Technologies forCervical Cancer Screening Working Group. Results at recruitmentfrom a randomized controlled trial comparing human papillomavirustesting alone with conventional cytology as the primary cervicalcancer screening test. J Natl Cancer Inst 100:492-501.
  • Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS,Rogovskaya SI, Arbyn M, Syrjanen S. (2013) Humanpapillomavirus prevalence and type-distribution, cervical cancerscreening practices and current status of vaccination implementationin Central and Eastern Europe. Vaccine 31 Suppl 7:H59-70.
  • Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of theworldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29.
  • Persson M, Brismar Wendel S, Ljungblad L, Johansson B,Weiderpass E, Andersson S (2012) High-risk human papillomavirusE6/E7 mRNA and L1 DNA as markers of residual/recurrent cervicalintraepithelial neoplasia. Oncol Rep 28:346-352.
  • Pannier-Stockman C, Segard C, Bennamar S, Gondry J, BoulangerJC, Sevestre H, Castelain S, Duverlie G (2008) Prevalence of HPVgenotypes determined by PCR and DNA sequencing in cervicalspecimens from French women with or without abnormalities. J ClinVirol 42:353?360.
  • Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K,Kita T, Yamamoto K, Mikami M, Takizawa K (2014) Potentialimpact of combined high- and low-risk human papillomavirusinfection on the progression of cervical intraepithelial neoplasia 2. JObstet Gynaecol Res 40:561-569.
  • Naoko K, Ayano S, Akifumi K, Hiroyuki S (2012) Productivelifecycle of human papillomaviruses that depends upon squamousepithelial differentiation. Front Microbiol 3:152-163.
  • Munoz N, Bosch X, de Sanjose S, Herrero R, Castellsague X, Shah94KV, Snijders PJF, Meijer CJLM (2003) Epidemiologic classificationof human papillomavirus types associated with cervical cancer. NEngl J Med 348:518?527.
  • McLaughlin-Drubin ME, Munger K (2009) The humanpapillomavirus E7 oncoprotein. Virology 384:335-344.
  • Mantovani F, Banks L (1999) The interaction between p53 andpapillomaviruses. Semin Cancer Biol 9:387?395.
  • Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R,Onsrud M, Thoresen S (2005) DNA-versus RNA-based methods forhuman papillomavirus detection in cervical neoplasia. GynecolOncol 97:908-915.
  • Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM(2011) Human papillomavirus type distribution in 30,848 invasivecervical cancers worldwide: Variation by geographical region,histological type and year of publication. Int J Cancer 128:927-935.
  • Lee DS, Kim SH, Park SJ, Jin HW, Kim TU, Park KH, Lee HY99(2011) Human papillomavirus prevalence in gangwon provinceusing reverse blot hybridization assay. Korean J Pathol 45:348-353.
  • Klingelhutz AJ, Roman A (2012) Cellular transformation by human97papillomaviruses: lessons learned by comparing high- and low-riskviruses. Virology 424:77-98.
  • Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T(2008) Population-based prevalence, type- and age-specificdistribution of HPV in women before introduction of an HPVvaccinationprogram in Denmark. Int J Cancer 123:1864?1870.
  • Kim SH, Lee DS, Park SJ, Kim TU, Jeon BY, Park KH, Lee HY(2012) REBA HPV-ID?? for efficient genotyping of humanpapillomavirus in clinical samples from Korean patients. J MedVirol 84:1248-1253.
  • Kim SH, Lee DS, Kim Y, Kim GH, Park SJ, Choi YI, Kim TU,Park KH, Lee HY (2012) Clinical evaluation of humanpapillomavirus DNA genotyping assay to diagnose women cervicalcancer. J Exp Biomed Sci 18:123-130.
  • Juric D, Mahovli? V, Rajhvajn S, Ovanin-Raki? A, Skopljanac-Macina L, Barisi? A, Proji? IS, Babi? D, Susa M, Corusi? A,Oreskovi? S (2010) Liquid-based cytology--new possibilities in thediagnosis of cervical lesions. Coll Antropol 34:19-24.
  • Jennifer Laudadio (2013) Human Papillomavirus Detection: TestingMethodologies and Their Clinical Utility in Cervical CancerScreening. Adv Anat Pathol 20:158-167.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011)Global cancer statistics. CA Cancer J Clin 61:69-90.
  • Howie HL, Katzenellenbogen RA, Galloway DA (2009) Thehuman Papillomavirus E6 proteins. Virology 384:324-334.
  • Hong SR, Kim IS, Kim DW, Kim MJ, Kim AR, Kim YO, Kim HS,Rha SH, Park GS, Park YK, Park YS, Park HS, Suh KS, Sohn JH,Shin MK, Oh HK, Yun KJ, Yoon HK, Lee SN, Lee AW, Lee HJ,Cho HY, Choi C, Jung WW (2009) Prevalence and GenotypeDistribution of Cervical Human Papillomavirus DNA in KoreanWomen: A Multicenter Study. Korean J Pathol 434-342.
  • Gaarenstroom KN, Melkert P, Walboomers JM, Van Den Brule AJ,Van Bommel PF, Meyer CJ, Voorhorst FJ, Kenemans P,Helmerhorst TJ (1994) Human papillomavirus DNA and genotypes:prognostic factors for progression of cervical intraepithelialneoplasia. Int J Gynecol Cancer 4:73-78.
  • Ergunay K, Misirlio?lu M, Pinar F, Tuncer ZS, Tuncer S,Ustacelebi S (2007) Human papilloma virus DNA in cervicalsamples with cytological abnormalities and typing of the virus.Mikrobiyol Bul 41:219-226.
  • Dyson N, Howley PM, Munger K, Harlow E (1989) The humanpapillomavirus-16 E7 oncoprotein is able to bind to theretinoblastoma gene product. Science 243: 934-940.
  • Ding X, Liu Z, Su J, Yan D, Sun W, Zeng Z. (2014) Humanpapillomavirus type-specific prevalence in women referred forcolposcopic examination in Beijing. J Med Virol 86:1937-1943.
  • Coquillard G, Palao B, Patterson BK (2011) Quantification ofintracellular HPV E6/E7 mRNA expression increases the specificityand positive predictive value of cervical cancer screening comparedto HPV DNA. Gynecol Oncol 120:89?93.
  • Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ,Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M,Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S,Thomas JO, Tunsakul S, Meijer CJ, Franceschi S (2005) Worldwidedistribution of human papillomavirus types in cytologically normalwomen in the International Agency for Research on Cancer HPVprevalence surveys: a pooled analysis. Lancet 366:991?998.
  • Cattani P, Siddu A, D'Onghia S, Marchetti S, Santangelo R,Vellone VG, Zannoni GF, Fadda G (2009) RNA (E6 and E7) assaysversus DNA (E6 and E7) assays for risk evaluation for womeninfected with human papillomavirus. J Clin Microbiol 47:2136-2141.
  • Castle PE, Dockter J, Giachetti C, Garcia FA, McCormick MK,101Mitchell AL, Holladay EB, Kolk DP (2007) A cross-sectional studyof a prototype carcinogenic human papillomavirus E6/E7 messengerRNA assay for detection of cervical precancer and cancer. ClinCancer Res 13:2599-2605.
  • Castellsague X, Schneider A, Kaufmann AM, Bosch FX (2009)HPV vaccination against cervical cancer in women above 25 yearsof age: key considerations and current perspectives. Gynecol Oncol115:S15-23.
  • Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S98(2010) Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytologicalfindings. J Infect Dis 1789?1799.
  • Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F,Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V(2009) A review of human carcinogens?part B: biological agents.Lancet Oncol 10:321?322.
  • Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J,Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalenceof human papillomavirus in cervical cancer: a worldwideperspective. International biological study on cervical cancer(IBSCC) study group. J Natl Cancer Inst 87:796-802.
  • Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S,Bruni L, Tortolero-Luna G, Kjaer SK, Munoz N (2008)Epidemiology and natural history of human papillomavirusinfections and type-specific implications in cervical neoplasia.Vaccine 26 Suppl 10-20.100
  • Bonnez W (1993) Taxonomy of the human papillomaviruses. ClinInfect Dis 17:1080.95
  • Bao YP, Li N, Smith JS, Qiao YL (2008) Human papillomavirustype distribution in women from Asia: a meta-analysis. Int JGynecol Cancer 18:71-79.
  • Andersson E, Karrberg C, Radberg T, Blomqvist L, Zetterqvist BM,Ryd W, Lindh M, Horal P (2011) Type-specific humanpapillomavirus E6/E7 mRNA detection by real-time PCR improvesidentification of cervical neoplasia. J Clin Microbiol 49:3794-3799.
  • Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L (2009)Prevalence and type distribution of high-risk human papillomavirusinfection in women undergoing voluntary cervical cancer screeningin Italy. J Med Virol 81:529-535.